DTIC-DOME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dtic-dome, and when can generic versions of Dtic-dome launch?
Dtic-dome is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in DTIC-DOME is dacarbazine. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dacarbazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dtic-dome
A generic version of DTIC-DOME was approved as dacarbazine by MEITHEAL on August 27th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DTIC-DOME?
- What are the global sales for DTIC-DOME?
- What is Average Wholesale Price for DTIC-DOME?
Summary for DTIC-DOME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Patent Applications: | 4,660 |
| DailyMed Link: | DTIC-DOME at DailyMed |
US Patents and Regulatory Information for DTIC-DOME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | DTIC-DOME | dacarbazine | INJECTABLE;INJECTION | 017575-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Hlthcare | DTIC-DOME | dacarbazine | INJECTABLE;INJECTION | 017575-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
